Short-term debt and current portion of long-term debt
Gilead Sciences Short-term debt and current portion of long-term debt decreased by 53.2% to $1.31B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 53.2%, from $2.81B to $1.31B. Over 5 years (FY 2020 to FY 2025), Short-term debt and current portion of long-term debt shows relatively stable performance with a 0.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Lower levels reduce immediate liquidity pressure, while high levels may signal a need for refinancing or significant cash outflows.
Detailed definition
The portion of total debt obligations, including bank loans and notes, that is due for repayment within the next twelve...
Peer comparison
A key indicator of short-term financial health compared to peers with similar capital structures.
other_debt_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.26B | $2.51B | $1.52B | $1.03B | $1.02B | $2.27B | $2.27B | $2.28B | $4.04B | $1.79B | $1.80B | $3.67B | $1.81B | $1.81B | $1.82B | $2.81B | $2.81B | $2.81B | $2.81B | $1.31B |
| QoQ Change | — | +11.1% | -39.6% | -32.4% | -0.4% | +122.3% | +0.1% | +0.4% | +76.8% | -55.6% | +0.3% | +103.9% | -50.6% | +0.1% | +0.2% | +54.6% | +0.0% | +0.0% | +0.0% | -53.2% |
| YoY Change | — | — | — | — | -54.8% | -9.6% | +49.9% | +122.7% | +295.4% | -21.0% | -20.9% | +60.6% | -55.2% | +1.1% | +0.9% | -23.5% | +55.0% | +54.9% | +54.7% | -53.2% |
Short-term debt and current portion of long-term debt at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's short-term debt and current portion of long-term debt?
- Gilead Sciences (GILD) reported short-term debt and current portion of long-term debt of $1.31B in Q1 2026.
- How has Gilead Sciences's short-term debt and current portion of long-term debt changed year-over-year?
- Gilead Sciences's short-term debt and current portion of long-term debt decreased by 53.2% year-over-year, from $2.81B to $1.31B.
- What is the long-term trend for Gilead Sciences's short-term debt and current portion of long-term debt?
- Over 5 years (2020 to 2025), Gilead Sciences's short-term debt and current portion of long-term debt has grown at a 0.4% compound annual growth rate (CAGR), from $2.76B to $2.81B.
- What does short-term debt and current portion of long-term debt mean?
- The amount of debt that must be paid back within one year.